SynBiotic SE (SBX.DE)

EUR 4.6

(-3.97%)

Revenue Summary of SynBiotic SE

  • SynBiotic SE's latest annual revenue in 2023 was 3.86 Million EUR , down -52.71% from previous year.
  • SynBiotic SE's latest quarterly revenue in 2023 FY was 3.86 Million EUR , down -52.71% from previous quarter.
  • SynBiotic SE reported a annual revenue of 8.16 Million EUR in annual revenue 2022, down -9.91% from previous year.
  • SynBiotic SE reported a annual revenue of 9.06 Million EUR in annual revenue 2021, up 65.63% from previous year.
  • SynBiotic SE reported a quarterly revenue of - EUR for 2023 Q2, down 0.0% from previous quarter.
  • SynBiotic SE reported a quarterly revenue of 18.51 Thousand EUR for 2022 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of SynBiotic SE (2023 - 2018)

Historical Annual Revenue of SynBiotic SE (2023 - 2018)

Year Revenue Revenue Growth
2023 3.86 Million EUR -52.71%
2022 8.16 Million EUR -9.91%
2021 9.06 Million EUR 65.63%
2020 5.47 Million EUR 0.0%
2019 - EUR 0.0%
2018 - EUR 0.0%

Peer Revenue Comparison of SynBiotic SE

Name Revenue Revenue Difference
MPH Health Care AG 34.43 Million EUR 88.785%
Apontis Pharma AG 36.96 Million EUR 89.554%
Dermapharm Holding SE 1.13 Billion EUR 99.66%
Evotec SE 781.42 Million EUR 99.506%
MERCK Kommanditgesellschaft auf Aktien 20.99 Billion EUR 99.982%
PharmaSGP Holding SE 101.09 Million EUR 96.181%